Related references
Note: Only part of the references are listed.Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe
M. H. Y. Tang et al.
CLINICAL TOXICOLOGY (2014)
New phenethylamines in Europe
L. A. King
DRUG TESTING AND ANALYSIS (2014)
Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication
Justin L. Poklis et al.
DRUG TESTING AND ANALYSIS (2014)
The rise of new psychoactive substance use in Australia
Lucy Burns et al.
DRUG TESTING AND ANALYSIS (2014)
New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?
Claudio Vidal Gine et al.
DRUG TESTING AND ANALYSIS (2014)
Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products
Nahoko Uchiyama et al.
FORENSIC TOXICOLOGY (2014)
Designer Psychostimulants in Urine by Liquid Chromatography-Tandem Mass Spectrometry
Sarah Kerrigan et al.
JOURNAL OF FORENSIC SCIENCES (2014)
The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample
Will Lawn et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response
Adam L. Halberstadt et al.
NEUROPHARMACOLOGY (2014)
2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl] ethanamine (25I-NBOMe): Clinical Case with Unique Confirmatory Testing
Samuel J. Stellpflug et al.
JOURNAL OF MEDICAL TOXICOLOGY (2014)
High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum
Justin L. Poklis et al.
BIOMEDICAL CHROMATOGRAPHY (2013)
Cross-reactivities of 41 new amphetamine designer drugs to EMITA® immunoassays
Maria Nieddu et al.
FORENSIC TOXICOLOGY (2013)
Analysis of 4-Bromo-2,5-DimethoxyphenethylamineAbuser's Urine: Identification and Quantitation of Urinary Metabolites
Tatsuyuki Kanamori et al.
JOURNAL OF FORENSIC SCIENCES (2013)
Preclinical Safety Assessment of the 5-HT2A Receptor Agonist PET Radioligand [11C]Cimbi-36
Anders Ettrup et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats
Tomas Palenicek et al.
PSYCHOPHARMACOLOGY (2013)
2C or Not 2C: Phenethylamine Designer Drug Review
Be Vang Dean et al.
JOURNAL OF MEDICAL TOXICOLOGY (2013)
4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects
Fernando Caudevilla-Galligo et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor
Maria Elena Silva et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2011)
Persistent psychosis after ingestion of a single tablet of '2C-B'
Hsiang Hsuan Huang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Cerebral Vasculopathy After 4-Bromo-2, 5-Dimethoxyphenethylamine Ingestion
Josiah B. Ambrose et al.
NEUROLOGIST (2010)
High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO):: A high-affinity 5-HT2A receptor-selective agonist radioligand
David E. Nichols et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT2A receptors
Antoni R. Blaazer et al.
CHEMMEDCHEM (2008)
Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration
Miroslava Rohanova et al.
TOXICOLOGY LETTERS (2008)
Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors
Pablo R. Moya et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-β-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry
Denis S. Theobald et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Simultaneous determination of psychotropic phenylalkylamine derivatives in human hair by gas chromatography/mass spectrometry
Jin Young Kim et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2007)
A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes
T Kanamori et al.
FORENSIC SCIENCE INTERNATIONAL (2005)
Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human
H Carmo et al.
TOXICOLOGY (2005)
A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs
D de Boer et al.
PHARMACY WORLD & SCIENCE (2004)
Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis
ME Soares et al.
BIOMEDICAL CHROMATOGRAPHY (2004)
4-Bromo-2,5-dimethoxyphenethylamine (2C-B): a review of the public domain literature
MD Cole et al.
SCIENCE & JUSTICE (2002)
Automated headspace solid-phase microextraction and in-matrix derivatization for the determination of amphetamine-related drugs in human urine by gas chromatography-mass spectrometry
A Namera et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2002)
In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: Identification of urinary metabolites
T Kanamori et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2002)
Share Paper
